GlassScriptPhysician profile
Muhammad Siddique Pir
NPI 1982137543
$5,168.01
in general payments reported to CMS, 2019-2025
19 companies · $555 in 2025
The $555 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,316 · 2023: $230 · 2024: $2,067 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513 · Grant: $1,063 · Education: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.24 |
| Grant | $1,063.30 |
| Education | $274.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,149.74 | 2022-2024 | |
| Shockwave Medical, INC | $475.38 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $262.49 | 2024-2025 | Lifevest |
| Abbott Laboratories | $257.75 | 2023-2024 | Ultreon, Diamondback Coronary |
| Abiomed | $162.72 | 2024-2025 | Impella |
| Merck Sharp & Dohme LLC | $136.88 | 2025 | Winrevair, Verquvo |
| Medtronic, INC. | $136.06 | 2022 | |
| Edwards Lifesciences Corporation | $126.76 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amgen INC. | $93.98 | 2022 | |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Scpharmaceuticals INC. | $64.60 | 2025 | |
| Baxter Healthcare | $36.43 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $35.71 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $31.64 | 2025 | Assure Wcd |
| Novo Nordisk INC | $31.45 | 2024 | Wegovy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $31.27 | 2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.51 | 2024 | Jardiance |
| Argon Medical Devices, INC. | $17.62 | 2025 | Clot Management |
| Bayer Healthcare Pharmaceuticals INC. | $14.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Siddique Pir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.